Toggle navigation
Browse
Home
People
Departments & Colleges
Research
Research Area Overlaps
BCR-Abl tyrosine kinase inhibitor Nilotinib (Tasigna®) reverses ABCB1/Pgp- and ABCG2/BCRP-mediated multidrug resistance
Conference Poster (Faculty180)
Overview
Overview
cited authors
Tiwari, Amit K; Sodani, K; Wang, S; Kuang, Y H; Chen, X; Chen, K; Ashby, Charles Jr; Chen, Z S
publication date
2010
presented at event
101st American Assoc for Cancer Research (AACR)
Conference